Review Article
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors
Figure 3
Plasma Cg A in patients with confirmed progression of colorectal NENs. Baseline levels and concentration of Cg A during follow-up of patients with metastatic colorectal NENs is no different (a) as observed during small bowel neuroendocrine tumor progression (b) [65].
(a) Colorectal NEN |
(b) Small bowel NEN |